Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TEMOZOLOMIDE Cause Post procedural complication? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Post procedural complication have been filed in association with TEMOZOLOMIDE (TEMOZOLOMIDE). This represents 0.0% of all adverse event reports for TEMOZOLOMIDE.

5
Reports of Post procedural complication with TEMOZOLOMIDE
0.0%
of all TEMOZOLOMIDE reports
1
Deaths
2
Hospitalizations

How Dangerous Is Post procedural complication From TEMOZOLOMIDE?

Of the 5 reports, 1 (20.0%) resulted in death, 2 (40.0%) required hospitalization.

Is Post procedural complication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TEMOZOLOMIDE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does TEMOZOLOMIDE Cause?

Disease progression (1,562) Death (1,403) Off label use (1,357) Product use in unapproved indication (1,353) Thrombocytopenia (1,300) Drug ineffective (1,131) Nausea (1,071) Neutropenia (809) Malignant neoplasm progression (779) Fatigue (766)

What Other Drugs Cause Post procedural complication?

ADALIMUMAB (2,494) ETANERCEPT (318) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (244) UPADACITINIB (241) RISANKIZUMAB-RZAA (232) INFLIXIMAB (217) METHOTREXATE (188) TREPROSTINIL (174) HUMAN IMMUNOGLOBULIN G (159) PREDNISONE (157)

Which TEMOZOLOMIDE Alternatives Have Lower Post procedural complication Risk?

TEMOZOLOMIDE vs TEMSIROLIMUS TEMOZOLOMIDE vs TENAMFETAMINE TEMOZOLOMIDE vs TENAPANOR TEMOZOLOMIDE vs TENECTEPLASE TEMOZOLOMIDE vs TENELIGLIPTIN

Related Pages

TEMOZOLOMIDE Full Profile All Post procedural complication Reports All Drugs Causing Post procedural complication TEMOZOLOMIDE Demographics